Alembic Accelerates: USFDA Approval for Carbamazepine 200 mg Fuels Global Ambitions

Unknown Apr 02, 2026 750 Views

Alembic Pharmaceuticals Limited today announced that it has received final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Carbamazepine Tablets USP, 200 mg. These tablets are therapeutically equivalent to Tegretol Tablets 200 mg of No...